![]()
-
[1]
Design, synthesis, evaluation and molecular modeling of quinazoline derivatives bearing amino acids as small-molecule PD-L1 inhibitors.Journal of Computer-Aided Molecular Design.2025,39::55
-
[2]
Discovery of novel biphenyl compounds bearing hydroxamic acid moiety as the first PD-L1/class I HDACs dual inhibitors.Journal of Enzyme Inhibition and Medicinal Chemistry.2025,40(1):2461190
-
[3]
Design, Synthesis, and Evaluation of 8-(o-Tolyl)quinazoline Derivatives as Small-Molecule PD-1/PD-L1 Antagonists.ACS Medicinal Chemistry Letters.2024,15:518-523
-
[4]
Advances in nonclassical phenyl bioisosteres for drug structural optimization.Future Medicinal Chemistry.2022,14:1681-1692
-
[5]
Advances in research on 3C-like protease (3CLpro) inhibitors against SARS-CoV-2 since 2020.RSC Med. Chem..2022,14:9-21
-
[6]
Discovery of quinazoline derivatives as novel small-molecule inhibitors targeting the programmed cell death-1/programmed cell death-ligand 1 (PD-1/PD-L1) interaction.European Journal of Medicinal Chemistry.2022,229:113998
